Cargando…

Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis

INTRODUCTION: A comprehensive conclusion has yet to be made about the predictive value of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) for stroke/systemic embolic events (SEE) in patients with atrial fibrillation (AF). This study aims to review the evidence for evaluating the value of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmadzadeh, Koohyar, Hajebi, Amirali, Adel Ramawad, Hamzah, Azizi, Yaser, Yousefifard, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shahid Beheshti University of Medical Sciences 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807953/ https://www.ncbi.nlm.nih.gov/pubmed/36620735 http://dx.doi.org/10.22037/aaem.v11i1.1808

Ejemplares similares

Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke: A Systematic Review
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Apelin as a Candidate for Hypertension Management; a Systematic Review and Meta-Analysis on Animal Studies
por: Mohammadi, Mohammad, et al.
Publicado: (2022)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Lack of concordance between reporting guidelines and risk of bias assessments of preclinical studies: a call for integrated recommendations
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
por: Ghazal, Faris, et al.
Publicado: (2019)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

Prognostic Value of CRASH and IMPACT Models for Predicting Mortality and Unfavorable Outcome in Traumatic Brain Injury; a Systematic Review and Meta-Analysis
por: Zarei, Hamed, et al.
Publicado: (2023)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation
por: Kim, Woo Shin, et al.
Publicado: (2011)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
por: Shen, Zican, et al.
Publicado: (2022)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
por: Palà, Elena, et al.
Publicado: (2019)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
por: Xiao, Jun, et al.
Publicado: (2021)

Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study
por: Xing, Lucas Yixi, et al.
Publicado: (2023)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Impact of Body Mass Index on Plasma N-Terminal ProB-Type Natriuretic Peptides in Chinese Atrial Fibrillation Patients without Heart Failure
por: Zheng, Li-hui, et al.
Publicado: (2014)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
por: Weiss, Noel S, et al.
Publicado: (2021)

Predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide level for atrial fibrillation recurrence after radiofrequency catheter ablation
por: Zhao, Qing, et al.
Publicado: (2023)

Muscimol as a treatment for nerve injury-related neuropathic pain: a systematic review and meta-analysis of preclinical studies
por: Ramawad, Hamzah Adel, et al.
Publicado: (2023)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Premature Coronary Artery Disease and Plasma Levels of Interleukins; a Systematic Scoping Review and Meta-Analysis
por: Haji Aghajani, Mohammad, et al.
Publicado: (2022)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2019)

The value of Coronary Artery Disease – Reporting and Data System (CAD-RADS) in Outcome Prediction of CAD Patients; a Systematic Review and Meta-analysis
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

HEART versus GRACE Score in Predicting the Outcomes of Patients with Acute Coronary Syndrome; a Systematic Review and Meta-Analysis
por: Kabiri, Ali, et al.
Publicado: (2023)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

Correlation between N‐terminal pro‐atrial natriuretic peptide, corin, and target organ damage in hypertensive disorders of pregnancy
por: Zhang, Wei, et al.
Publicado: (2022)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ts93tjm8muc9tdjcnojtaaajr